Colorectal cancer (CRC) is a disease of the older population in developed countries where the incidence among the young is rising despite the decline in the overall incidence. The recent trends show a rise in cases of CRC in India particularly in young individuals. CRC is the fourth most common cancer in India. The survival rate in India is much less in comparison to the developed countries, ranking fifth in CRC related mortality globally.
Risk factors include consumption of red and processed meat, fried and sugary food, smoking and alcohol, comorbidities such as obesity, diabetes and inflammatory bowel disease (IBD), family history of CRC, adenomas and genetic syndromes, radiation exposure, pesticides and asbestos.
While colonoscopy remains the gold standard for detecting CRC, the rising cases highlight the need for popularising the ‘At-home screening’ kits in India.They can help in early detection of cases and also are less invasive and more acceptable to the person undergoing these tests. They are simple and accurate.
These tests are:
-
Fecal occult blood test( FOBT) - detects blood in stool.
-
Fecal immunochemical test ( FIT) - detects blood from lower intestines in the stool and tends to be more accurate.
-
Cologuard - checks for evidence of DNA shed by cancer cells in the stool, as well as for blood.
FOBT and FIT are done annually and Cologuard is recommended every three years, if negative. Accuracy of FOBT, FIT and Cologuard is around 71%,80% and 92% respectively. If the tests are positive a colonoscopy is recommended. The samples are sent to lab for testing.
The drawback is that these test are not very effective in detecting polyps. Also the At-home tests aren’t recommended for people who have a personal or family history of colorectal cancer or gastrointestinal disorders such as inflammatory bowel disease.
Survival rates remain low in India largely due to delayed detection and limited awareness. Promoting awareness, improving accessibility to screening, and encouraging early evaluation of symptoms are essential steps in reducing CRC-related morbidity and mortality. At policy level, a national screening should be introduced.
With rising cases among the young, can we afford to delay widespread screening and awareness any longer?
MBH/PS